INTERSTITIAL LUNG DISEASES
Clinical trials for INTERSTITIAL LUNG DISEASES explained in plain language.
Never miss a new study
Get alerted when new INTERSTITIAL LUNG DISEASES trials appear
Sign up with your email to follow new studies for INTERSTITIAL LUNG DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug could slow lung damage in autoimmune patients
Disease control Recruiting nowThis study tests a medicine called nerandomilast for people with lung scarring caused by autoimmune diseases like rheumatoid arthritis or scleroderma. About 400 adults who still have lung problems despite standard treatment will take either the drug or a placebo for at least 26 w…
Matched conditions: INTERSTITIAL LUNG DISEASES
Phase: PHASE3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
New drug hope for lung scarring: anlotinib trial begins
Disease control Recruiting nowThis study tests whether anlotinib capsules can improve lung function in people with idiopathic pulmonary fibrosis (IPF) or progressive fibrosis-interstitial lung diseases (PF-ILDs). About 30 adults aged 40-85 will receive either anlotinib or a placebo. The main goal is to see if…
Matched conditions: INTERSTITIAL LUNG DISEASES
Phase: PHASE2, PHASE3 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated May 08, 2026 12:02 UTC
-
Hope for families: new drug aims to stop lung scarring before it starts
Prevention Recruiting nowThis study tests a medicine called nerandomilast in people aged 40 and older who have early lung changes and a family history of pulmonary fibrosis. Participants take the drug or a placebo twice daily for about 2-3 years. The goal is to see if the drug can slow or prevent worseni…
Matched conditions: INTERSTITIAL LUNG DISEASES
Phase: PHASE3 • Sponsor: Boehringer Ingelheim • Aim: Prevention
Last updated May 22, 2026 13:54 UTC
-
New CT scan study aims to catch hidden heart damage in lung disease patients
Knowledge-focused Recruiting nowThis study will use advanced CT scans to look at both the lungs and heart in 123 adults with interstitial lung disease (ILD). The goal is to find better ways to detect and measure lung damage and hidden heart problems early. Researchers hope this will help doctors predict and man…
Matched conditions: INTERSTITIAL LUNG DISEASES
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated May 26, 2026 06:50 UTC
-
Scientists decode mysterious ultrasound signals in lung patients
Knowledge-focused Recruiting nowThis study aims to better understand the physical causes of certain patterns seen on lung ultrasound images in people with interstitial lung disease or COPD. Researchers will compare ultrasound findings with CT scans in 25 patients to link artifacts to specific lung changes. The …
Matched conditions: INTERSTITIAL LUNG DISEASES
Phase: NA • Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated May 22, 2026 13:50 UTC
-
Massive 10-Year study aims to unlock secrets of rare lung disease
Knowledge-focused Recruiting nowThis study follows 3000 children and adults with interstitial lung disease, along with their relatives, for up to 10 years. Researchers will collect medical records, genetic samples, and test results to better understand how the disease develops and progresses. The goal is to ide…
Matched conditions: INTERSTITIAL LUNG DISEASES
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated May 19, 2026 12:01 UTC